tetano
Editor, Senior Moderator
J Med Virol
. 2021 Jul 27.
doi: 10.1002/jmv.27232. Online ahead of print.
Acute Cerebellitis following SARS-CoV-2 infection: A Case Report and Review of Literature
Maria C Moreno-Escobar[SUP] 1 [/SUP], Parissa Feizi[SUP] 2 [/SUP], Sanjiti Podury[SUP] 3 [/SUP], Medha Tandon[SUP] 4 [/SUP], Badria Munir[SUP] 1 [/SUP], Muhammad Alvi[SUP] 1 [/SUP], Amelia Adcock[SUP] 1 5 [/SUP], Shitiz Sriwastava[SUP] 1 5 [/SUP]
Affiliations
Abstract
The novel coronavirus disease (COVID-19) first described in Wuhan, China in December 2019, rapidly spread across the world and has become a global public health emergency. The literature on the neurological manifestations of COVID-19 is limited. We report a 24-year-old male who presented with vertigo, dysarthria and bradyphrenia 3 weeks after being diagnosed with COVID-19 on nasopharyngeal RT-PCR. The patient was diagnosed with acute cerebellitis based on MRI features and showed improvement post treatment with I.V methylprednisone for five days. The scope of this article is to highlight the importance of early identification of neurological symptoms and timely management as the outcomes may be catastrophic. This article is protected by copyright. All rights reserved.
Keywords: COVID-19; Cerebellitis; SARS-CoV-2.
. 2021 Jul 27.
doi: 10.1002/jmv.27232. Online ahead of print.
Acute Cerebellitis following SARS-CoV-2 infection: A Case Report and Review of Literature
Maria C Moreno-Escobar[SUP] 1 [/SUP], Parissa Feizi[SUP] 2 [/SUP], Sanjiti Podury[SUP] 3 [/SUP], Medha Tandon[SUP] 4 [/SUP], Badria Munir[SUP] 1 [/SUP], Muhammad Alvi[SUP] 1 [/SUP], Amelia Adcock[SUP] 1 5 [/SUP], Shitiz Sriwastava[SUP] 1 5 [/SUP]
Affiliations
- PMID: 34314031
- DOI: 10.1002/jmv.27232
Abstract
The novel coronavirus disease (COVID-19) first described in Wuhan, China in December 2019, rapidly spread across the world and has become a global public health emergency. The literature on the neurological manifestations of COVID-19 is limited. We report a 24-year-old male who presented with vertigo, dysarthria and bradyphrenia 3 weeks after being diagnosed with COVID-19 on nasopharyngeal RT-PCR. The patient was diagnosed with acute cerebellitis based on MRI features and showed improvement post treatment with I.V methylprednisone for five days. The scope of this article is to highlight the importance of early identification of neurological symptoms and timely management as the outcomes may be catastrophic. This article is protected by copyright. All rights reserved.
Keywords: COVID-19; Cerebellitis; SARS-CoV-2.